The potential utility of B cell-directed biologic therapy in autoimmune diseases.

Authors:
Arkfeld DG.

Journal:
Rheumatol Int

Publication Year: 2007

DOI:
10.1007/s00296-007-0471-x

PMCID:
PMC2134974

PMID:
17957371

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Rheumatol Int

Abbreviation: Rheumatol Int

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Rheumatology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Cross-sectional analysis of cardiovascular disease and risk factors in patients with spondyloarthri…
Duruöz MT; Bodur H; Ataman Ş and 13 more (2024) - Transparency Score: 3/6
Trends in health care of patients with vasculitides, including giant cell arteritis, Takayasu arter…
Henes J; Richter JG; Thiele K and 3 more (2024) - Transparency Score: 3/6
Analyzing web searches for axial spondyloarthritis in Germany: a novel approach to exploring intere…
Berr K; Tizek L; Schielein MC and 4 more (2023) - Transparency Score: 3/6
Apremilast for biologic-naïve, peripheral psoriatic arthritis, including patients with early diseas…
Sfikakis PP; Vassilopoulos D; Katsifis G and 19 more (2023) - Transparency Score: 3/6
Assessment of antibody levels to SARS-CoV-2 in patients with idiopathic inflammatory myopathies rec…
Bae SS; Faure-Kumar E; Ferbas K and 7 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
0/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025